Cryo Cell International (CCEL) Revenue (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Revenue data on file, last reported at $7.7 million in Q1 2026.

• Revenue for Q1 2026 came in at $7.7 million, down 3.59% year-over-year; the trailing twelve-month figure through Feb 2026 was $31.3 million (down 2.56% YoY), and the FY2025 annual result was $31.6 million, down 1.31% from the prior year.
• Revenue retreated to $7.7 million in Q1 2026 per CCEL's latest filing, from $7.8 million in the prior quarter.
• Over five years, Revenue peaked at $8.1 million in Q3 2024 and troughed at $7.3 million in Q1 2022.
• A 5-year average of $7.8 million and a median of $7.8 million in 2025 frame the typical range for Revenue.
• The sharpest annual moves came in 2023 and 2026: Revenue climbed 7.8% in 2023, then retreated 3.59% in 2026.
• A 5-year view of Revenue shows it stood at $7.8 million in 2022, then advanced by 1.45% to $7.9 million in 2023, then grew by 1.87% to $8.0 million in 2024, then decreased by 2.26% to $7.8 million in 2025, then dropped by 2.04% to $7.7 million in 2026.
• Business Quant data shows CCEL's Revenue at $7.7 million in Q1 2026, $7.8 million in Q4 2025, and $7.8 million in Q3 2025.